Asia Pacific Home Healthcare Market

Asia Pacific Home Healthcare Market Size, Share & Industry Trends Analysis Report By Type (Services and Product), By Indication, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-12867 Publication Date: December-2022 Number of Pages: 118
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Home Healthcare Market would witness market growth of 9.3% CAGR during the forecast period (2022-2028).

In hospitals, care is often uniform and straitjacket-styled for everyone. There isn't much space left to accommodate the patient's unique needs and independence. Patients may become unhappy as a result, in one way or another. Giving patients expert treatment at home helps to individualize and tailor their experience. They are made specifically for each patient and with the patient's requirements in mind.

The patient feels considerably more at ease as a result since all of his requirements are met. The patient recovers more quickly with personalized care since it offers one-on-one treatment that also meets medical requirements. Some individuals could find it challenging to take care of themselves and carry out simple duties like cleaning, cooking, grooming, and bathing. These everyday tasks are also made easier to do with the assistance of professional in-home care.

Additionally, these experts assist with simple domestic tasks like laundry and dishwashing, which helps maintain a respectable standard of living. A home health aide is qualified to assist patients with ADLs (Activities of daily living). This promotes patients' respect, dignity, and ability to live long, healthy life. The home nurses support the patient with all of their activities.

One of the world's fastest-growing aging populations is in China. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. For public health and socioeconomic development, this profound demographic shift creates a number of new challenges and opportunities. China has been investigating cutting-edge methods for enhancing access to integrated care. For these elderly folks, this would all lead to a rise in demand for home healthcare services. As a consequence, the Asia Pacific region's home healthcare industry would experience rapid expansion.

The China market dominated the Asia Pacific Home Healthcare Market by Country in 2021; thereby, achieving a market value of $31,124.1 million by 2028. The Japan market is registering a CAGR of 8.6% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 9.9% during (2022 - 2028).

Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy and Pregnancy Care. Based on Product Type, the market is segmented into Therapeutic Products, Testing, Screening, & Monitoring Products and Mobility Care Products. Based on Indication, the market is segmented into Cancer & Other Indications, Respiratory Diseases, Wound Care, Pregnancy, Movement Disorders, Hearing Disorders, Cardiovascular Diseases & Hypertension and Diabetes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Home Healthcare Market is Projected to reach USD 405.6 Billion by 2028, at a CAGR of 8.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Services
    • Skilled Nursing
    • Rehabilitation Therapy
    • Hospice & Palliative Care
    • Unskilled Care
    • Respiratory Therapy
    • Infusion Therapy
    • Pregnancy Care
  • Product
    • Therapeutic Products
    • Testing, Screening, & Monitoring Products
    • Mobility Care Products

By Indication

  • Cancer & Other Indications
  • Respiratory Diseases
  • Wound Care
  • Pregnancy
  • Movement Disorders
  • Hearing Disorders
  • Cardiovascular Diseases & Hypertension
  • Diabetes

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Amedisys, Inc.
  • LHC Group, Inc.
  • ResMed, Inc.
  • Omron Corporation
  • Abbott Laboratories
  • Invacare Corporation
  • Linde PLC
  • A&D HOLON Holdings Company, Limited
  • Fresenius SE & Co. KGaA
  • F.Hoffmann-La Roche Ltd.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo